Peptide drug manufacturing commonly uses large amounts of hazardous solvents primarily due to multiple washings after each step. Here, the authors introduce the concept of a completely wash-free methodology that enables up to 95% waste reduction.
- Jonathan M. Collins
- Sandeep K. Singh
- Christopher L. Houser